by Haja Mo October 1, 2026 Tech Researchers are asking why patients, like former Senator Ben Sasse, inevitably develop resistance to the drug daraxonrasib. Previous Story New Cancer Drugs Are Revolutionary. Why Don’t More Patients Get Them?
